488 related articles for article (PubMed ID: 33474998)
21. Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives.
Han H; Li S; Xu M; Zhong Y; Fan W; Xu J; Zhou T; Ji J; Ye J; Yao K
Adv Drug Deliv Rev; 2023 May; 196():114770. PubMed ID: 36894134
[TBL] [Abstract][Full Text] [Related]
22. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.
Qamar Z; Qizilbash FF; Iqubal MK; Ali A; Narang JK; Ali J; Baboota S
Recent Pat Drug Deliv Formul; 2019; 13(4):246-254. PubMed ID: 31884933
[TBL] [Abstract][Full Text] [Related]
23. Recent patents on ocular drug delivery systems.
Conway BR
Recent Pat Drug Deliv Formul; 2008; 2(1):1-8. PubMed ID: 19075892
[TBL] [Abstract][Full Text] [Related]
24. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
[TBL] [Abstract][Full Text] [Related]
25. Drug delivery to the posterior segment of the eye.
Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
[TBL] [Abstract][Full Text] [Related]
26. Drug delivery to the eye: what benefits do nanocarriers offer?
Joseph RR; Venkatraman SS
Nanomedicine (Lond); 2017 Mar; 12(6):683-702. PubMed ID: 28186436
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles for drug delivery to the anterior segment of the eye.
Janagam DR; Wu L; Lowe TL
Adv Drug Deliv Rev; 2017 Dec; 122():31-64. PubMed ID: 28392306
[TBL] [Abstract][Full Text] [Related]
29. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
[TBL] [Abstract][Full Text] [Related]
30. Depot formulations to sustain periocular drug delivery to the posterior eye segment.
Agban Y; Thakur SS; Mugisho OO; Rupenthal ID
Drug Discov Today; 2019 Aug; 24(8):1458-1469. PubMed ID: 30930148
[TBL] [Abstract][Full Text] [Related]
31. Nanotechnology in ocular delivery: current and future directions.
Sultana Y; Maurya DP; Iqbal Z; Aqil M
Drugs Today (Barc); 2011 Jun; 47(6):441-55. PubMed ID: 21695286
[TBL] [Abstract][Full Text] [Related]
32. Cell penetrating peptides in ocular drug delivery: State of the art.
Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
[TBL] [Abstract][Full Text] [Related]
33. Delivery of therapeutics for deep-seated ocular conditions - status quo.
Nguyen H; Eng S; Ngo T; Dass CR
J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
[TBL] [Abstract][Full Text] [Related]
34. Posterior drug delivery via periocular route: challenges and opportunities.
Waite D; Wang Y; Jones D; Stitt A; Raj Singh TR
Ther Deliv; 2017 Jul; 8(8):685-699. PubMed ID: 28730942
[TBL] [Abstract][Full Text] [Related]
35. Nanocarriers in ocular drug delivery: an update review.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
[TBL] [Abstract][Full Text] [Related]
36. Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy.
Swetledge S; Jung JP; Carter R; Sabliov C
J Nanobiotechnology; 2021 Jan; 19(1):10. PubMed ID: 33413421
[TBL] [Abstract][Full Text] [Related]
37. Prodrugs and nanomicelles to overcome ocular barriers for drug penetration.
Gote V; Ansong M; Pal D
Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):885-906. PubMed ID: 32729364
[TBL] [Abstract][Full Text] [Related]
38. Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.
Bisht R; Mandal A; Jaiswal JK; Rupenthal ID
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28425224
[TBL] [Abstract][Full Text] [Related]
39. Recent perspectives in ocular drug delivery.
Gaudana R; Jwala J; Boddu SH; Mitra AK
Pharm Res; 2009 May; 26(5):1197-216. PubMed ID: 18758924
[TBL] [Abstract][Full Text] [Related]
40. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
